[Hepatitis B and delta infections in patients with tuberculosis].
Clinical variants of the course and outcomes of HBV and delta infections have been studied in pulmonary tuberculosis patients in the general structure of 1465 patients who were treated for hepatitis B. Enzyme immunoassay and radioimmunoassays were used to study the detection rate of contamination markers HBV activity and delta-virus replication in 437 pulmonary tuberculosis patients. Viruses were found to be predisposed to prolonged persistence and wide spread among tuberculosis patients.
Zhavoronok
S V
SV
Romanovskiĭ
R V
RV
Pavlovich
I L
IL
Volosevich
G V
GV
Ben'
V A
VA
Noland
O V
OV
Dotsenko
M L
ML
GerasimovAN
D015415:Biomarkers / Q000097:blood; D006508:Hepatitis Antibodies / Q000032:analysis / Q000276:immunology; D006509:Hepatitis B / Q000150:complications / Q000175:diagnosis* / Q000276:immunology; D006511:Hepatitis B Antigens / Q000276:immunology; D006515:Hepatitis B virus / Q000276:immunology; D003699:Hepatitis D / Q000150:complications / Q000175:diagnosis* / Q000276:immunology; D003698:Hepatitis Delta Virus / Q000276:immunology; D006801:Humans; D014397:Tuberculosis, Pulmonary / Q000150:complications* / Q000276:immunology
D015415:Biomarkers; D006508:Hepatitis Antibodies; D006511:Hepatitis B Antigens
Gepatit B i del'ta-infektsii u bol'nykh tuberkulezom.